Buy GHK-Cu 50 mg + bacteriostatic water
€33.54
GHK-Cu, 50 mg, with bacteriostatic water, is a copper(II) Gly-His-Lys complex for coordination chemistry, peptide analytics and in vitro laboratory research. Pharma Research .eu provides documented European supply subject to copper, purity and identity verification.
Buy GHK-Cu, 50 mg + Bacteriostatic Water, for Advanced Laboratory Research in Europe
GHK-Cu is a copper(II) coordination complex of the tripeptide glycyl-L-histidyl-L-lysine, commonly written Gly-His-LysβCu(II). It is supplied as a laboratory reagent for copperβpeptide coordination studies, analytical chemistry, spectroscopy and controlled in vitro investigations. Depending on ionic and hydration conventions, reported molecular masses range from approximately 401.9 to 403.9 Da. Pharma Research .eu presents this 50 mg format with bacteriostatic water for qualified European laboratory teams.peptide+2
Uncompromising Purity and Analytical Characterisation
GHK-Cu must be distinguished from free GHK. Free GHK is the copper-free tripeptide Gly-His-Lys, whereas GHK-Cu contains a coordinated copper(II) ion and has different molecular mass, charge, spectroscopy and metal-binding behaviour.axynpeptides.co+1
For procurement, the appropriate target is β₯99.0% peptide-related purity by RP-HPLC, complemented by copper-content and complex-identity testing. HPLC alone may not prove that the intended 1:1 copper complex is present, so a robust analytical package should combine chromatography with mass spectrometry and an orthogonal elemental or copper assay.
A complete CoA should include:
-
RP-HPLC purity percentage and chromatogram.
-
LC-MS, ESI-MS or high-resolution MS identity confirmation.
-
Copper-content or elemental analysis.
-
Gly-His-Lys sequence and stereochemical designation.
-
Copper-to-peptide stoichiometry, preferably demonstrating a 1:1 complex.
-
Formula and molecular mass for the supplied ionic or salt form.
-
Visual appearance of the lyophilised material.
-
Residual-solvent results from synthesis and purification.
-
Water or residual-moisture content, where measured.
-
Heavy-metal and elemental-impurity results, including non-copper metals where tested.
-
Lot number, manufacture date, retest date and storage requirements.
Public references variously report CββHββCuNβOβ, CββHββCuNβOβ and CββHββCuNβOβ, with molecular masses from approximately 401.9 to 403.9 g/mol. These differences may reflect charge, hydration or salt conventions, but the supplier must state the exact form supplied.peptide+3
GHK-Cu is generally supplied as a blue, blue-green or turquoise lyophilised solid. The colour may be consistent with copper coordination, but it is not proof of purity or complex identity. Visual inspection can identify gross discolouration, vial damage or visible contamination; analytical release should combine appearance assessment with RP-HPLC, mass spectrometry and copper-content testing.
High purity is essential because free GHK, unbound copper, copper hydrolysis products, peptide truncations and alternative copperβpeptide species may behave differently in spectroscopy, chromatography and cellular assays. A nominally high-purity peptide without confirmed copper stoichiometry may not be equivalent to a characterised GHK-Cu complex.
The bacteriostatic water is a separate reagent and should have its own label, expiry date, preservative information and documentation. Preservatives and trace ions can disturb copperβligand equilibria, alter pH or affect analytical and cellular workflows.
Principal Laboratory Applications and Research Methodologies
GHK-Cu is suitable for controlled laboratory research involving coordination chemistry, copperβpeptide interactions, analytical characterisation and in vitro model development. All applications should be conducted by qualified personnel within an appropriately governed university, CRO, pharmaceutical R&D or analytical laboratory.
Copperβpeptide coordination studies. GHK-Cu can be used to investigate copper binding, stoichiometry, pH dependence and competition with other ligands. Suitable approaches may include UVβvisible spectroscopy, circular dichroism, mass spectrometry, ion chromatography and elemental analysis. pH, ionic strength, buffer identity and free-copper background should be controlled.
RP-HPLC and LC-MS characterisation. The complex may support retention-time assignment, peptide-content analysis and detection of free GHK, unbound copper and related species. Metal binding may influence ionisation and chromatographic behaviour, so methods should include suitable copper-free and copper-containing controls.
In vitro biochemical assays. A verified lot may be incorporated into cell-free or cellular systems examining copper-dependent redox chemistry, peptideβmetal interactions or extracellular-matrix-associated biochemical pathways. Free GHK, copper-only and vehicle controls may be appropriate depending on the research question.
Formulation and stability studies. Laboratories may examine the influence of pH, light, temperature, oxygen, competing ligands and chelating agents on complex integrity. Stability-indicating methods should monitor both peptide concentration and copper content, since peptide-related HPLC signal alone may not confirm retention of the intended coordination state.
The 50 mg quantity corresponds to approximately 124 Β΅mol if calculated using 401.9 g/mol, or approximately 147 Β΅mol if calculated using the copper-free GHK mass of 340.38 g/mol. This difference illustrates why the supplied chemical form must be confirmed before converting mass to molar quantity.
No final solution concentration should be printed without a specified reconstitution volume, formula, purity, hydration state and copper stoichiometry. Bacteriostatic water should be evaluated separately for preservative effects, pH and possible interaction with the copper complex.
Compound Stability, Optimal Storage, and Safe Handling Protocols
Lyophilised GHK-Cu should generally be sealed, dry, protected from light and stored at approximately β20Β°C unless the lot-specific CoA specifies otherwise. Low-temperature, moisture-protected storage helps preserve both peptide integrity and the intended metalβligand state.axynpeptides.co+2
Recommended controls include:
-
Store unopened lyophilised GHK-Cu at β20Β°C unless the CoA specifies another condition.
-
Consider β80Β°C for extended archival storage where supported by the stability programme.
-
Protect the material from light, moisture and unnecessary oxygen exposure.
-
Allow a sealed vial to reach room temperature before opening to reduce condensation.
-
Use low-binding, metal-compatible containers where adsorption or contamination could affect recovery.
-
Prepare aliquots if repeated access is expected.
-
Store short-term aqueous solutions at 2β8Β°C only where validated.
-
Avoid repeated freezeβthaw cycles.
-
Avoid unvalidated chelating agents, strongly alkaline conditions and buffers that bind copper.
-
Record solvent, pH, concentration, preparation date, operator and storage history.
Copper can exchange ligands, hydrolyse or bind to container surfaces, buffers and contaminants. A clear or blue solution should not automatically be assumed to retain the original 1:1 complex. Stability studies should monitor peptide concentration, copper content and, where appropriate, spectroscopic coordination signatures.
Reconstitution should be performed using a validated laboratory procedure. Add the selected aqueous reagent gradually and mix gently. Avoid metal-contaminated tools, uncharacterised buffers and vigorous agitation. If precipitation, unexpected colour change or persistent turbidity occurs, investigate the material analytically before use.
Handling should follow the current SDS and institutional chemical-risk assessment. Appropriate precautions generally include a certified fume hood or suitable local containment, nitrile gloves, safety goggles and a laboratory coat. Avoid aerosol generation and contact with the powder or solution. Dispose of copper-containing and peptide-containing waste according to approved institutional chemical-waste procedures.
Technical Specifications and Molecular Attributes
| Attribute | Specification |
|---|---|
| Product | GHK-Cu, 50 mg, supplied with bacteriostatic water |
| Common designation | Copper tripeptide; copper(II) glycyl-L-histidyl-L-lysinate |
| Peptide sequence | Gly-His-Lys |
| Complex | 1:1 Cu(II)βGHK coordination complex |
| Residue count | 3 amino acids plus coordinated Cu(II) |
| IUPAC name | Copper(II) glycyl-L-histidyl-L-lysinate; confirm ionic and hydration form on the CoA |
| CAS Registry Number | 89030-95-5 is widely reported; verify the exact supplied form |
| Molecular formula | Commonly reported as CββHββCuNβOβ or related hydrated/charged equivalent |
| Average molecular mass | Approximately 401.9β403.9 g/mol, depending on form |
| Physical state and colour | Typically blue to blue-green lyophilised solid |
| Solubility profile | Aqueous compatibility may be feasible; pH, buffers, chelators and competing ligands require validation |
| Typical purity | Proposed target β₯99.0% peptide-related purity by RP-HPLC plus copper-content verification |
| Identity testing | RP-HPLC, LC-MS and copper or elemental assay |
| Companion reagent | Bacteriostatic water; volume and formulation should be confirmed on the packaging |
| Long-term storage | Typically β20Β°C, sealed, dry and protected from light |
The free GHK tripeptide and the GHK-Cu complex must not share one molecular specification. Current references report several formula and mass conventions for the complex, so the vendorβs CoA should state the exact ionic, hydration and salt form.peptide+3
Pharma Research .eu: Your Premier EU Vendor for High-Purity Reagents
Pharma Research .eu can position GHK-Cu as a documented European copperβpeptide reagent for analytical chemists, biochemists and laboratory managers. The product file should include a batch-specific CoA, SDS, peptide sequence, copper-content result, complex stoichiometry, purity result, identity data, formula, molecular mass and storage instructions.
Any claim that Pharma Research .eu operates an ISO 9001-certified quality-management system should be supported by a current certificate identifying the issuing body, scope and validity. Claims concerning discreet or temperature-controlled logistics across EU member states should likewise be verified for the destination, carrier route, packaging and applicable transport requirements.
A quality-focused supplier should be able to discuss:
-
Free GHK versus the GHK-Cu complex.
-
Copper stoichiometry and ionic or hydrated form.
-
RP-HPLC purity and LC-MS identity testing.
-
Copper and elemental-impurity analysis.
-
Residual solvents, moisture and container compatibility.
-
Buffer, chelator and reconstitution compatibility.
-
Storage, transport and documentation requirements.
Pharma Research .eu should therefore be described as a potential European source for research-grade GHK-Cu, with vendor-specific certification and logistics claims verified through current records. The material is intended strictly for controlled laboratory research and analytical use by qualified personnel under applicable institutional procedures.
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisqueΒ vestibulum amet elit ut volutpat.


Reviews
There are no reviews yet.